Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aquestive Therapeutics Inc.

2.88
+0.04981.76%
Volume:319.93K
Turnover:904.43K
Market Cap:285.22M
PE:-5.67
High:2.90
Open:2.81
Low:2.77
Close:2.84
Loading ...

Strength Seen in Recursion Pharmaceuticals (RXRX): Can Its 27.7% Jump Turn into More Strength?

Zacks
·
14 Apr

Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium

GlobeNewswire
·
09 Apr

Aquestive Therapeutics Announces Positive Topline Pk Results From Its Pediatric Study and Completes the Nda Submission for Anaphylm™ (Epinephrine) Sublingual Film

THOMSON REUTERS
·
01 Apr

Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film

GlobeNewswire
·
01 Apr

Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) P/S Is On The Mark

Simply Wall St.
·
22 Mar

Aquestive Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Mar

Raymond James Keeps Their Buy Rating on Aquestive Therapeutics (AQST)

TIPRANKS
·
07 Mar

Lake Street Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST)

TIPRANKS
·
07 Mar

Alliance Global Partners Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST)

TIPRANKS
·
07 Mar

Aquestive Therapeutics Inc : Raymond James Cuts Target Price to $7 From $8

THOMSON REUTERS
·
07 Mar

Aquestive Therapeutics Inc (AQST) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
07 Mar

Sector Update: Health Care Stocks Flat to Lower Premarket Thursday

MT Newswires Live
·
06 Mar

Aquestive Therapeutics Q4 Net Loss Widens, Revenue Falls; 2025 Revenue Outlook Issued

MT Newswires Live
·
06 Mar

Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics

Zacks
·
06 Mar

Aquestive Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Mar

BRIEF-Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Reuters
·
06 Mar

Aquestive Therapeutics (AQST) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
06 Mar

Aquestive Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
06 Mar

Aquestive Therapeutics Inc: Qtrly Shr Loss $0.19

THOMSON REUTERS
·
06 Mar

Aquestive Therapeutics Inc Outlook FY Total Revenue $47Mln to $56 Mln

THOMSON REUTERS
·
06 Mar